NN&I interviewed Leslie Trigg, CEO of Outset Medical, on the company's new Tablo dialysis machine, which is aimed at clinics who want to develop the self-care option for patients.
NN&l: What are Tablo's key attributes?
LESLIE TRIGG: The Tablo technology is aimed at meaningfully improving the care experience for patients and lowering labor, infrastructure, and clinical costs for providers. In dialysis clinics, this comes in the form of in-center self care in which patients are able to set up and manage their Tablo treatments independently.
Three key Tablo technology innovations enable this approach: consumer product design simplicity, integrated water purification with dialysate production on demand, and wireless medical informatics.
NN&l: Why is the Tablo a good fit for in-center self-care?
TRIGG: We've stayed very focused on minimizing the number of set up steps, eliminating memorization and mental math, and building a user experience to ensure it is accessible. In the clinic, that's translated into Tablo training times measured in single-digit hours, not weeks, and fast set up times that allow for self care to fit well into the clinic's existing workflow.
Read More: http://www.nephrology-digital.com/September2016/Default/19/0?token=B59Z9LXJFKB91GG7
By: Sarah S. Prichard, MD, FRCP(C) Glenn M. Chertow, MD, MPH
Innovator: Leslie Trigg
MedtechVision 2016: Global Medtech
Via: MedCity News
Last week, Omada Health, a San Francisco digital health startup, announced that it is partnering with the American Medical Association and Intermountain Healthcare, the Salt Lake City, Utah-based health system, to prevent the onset of diabetes in adult patients.
Via: IV Post
The American Medical Association (AMA), Omada Health, and Intermountain Healthcare today announced an innovative initiative aimed at reducing the alarming number of adults who develop type 2 diabetes. The new collaboration will create a roadmap for large health care organizations across the country to adopt proven online behavior change interventions for at-risk patients, and integrate those programs into provider referral and clinical workflow.
NEW YORK, New York (26 July 2016) – Today, Interbrand launches the inaugural Interbrand Breakthrough Brands report, in partnership with Facebook, Ready Set Rocket, and the New York Stock Exchange (NYSE). The Interbrand Breakthrough Brands report, entitled “Future Growth,” is unique in that it examines emerging companies that are brand-led—organizations that have both unique business models and strong brands. The report complements Interbrand’s annual Best Global Brands report, now entering its 17th year, by putting a spotlight on emerging brands—especially those that are affecting change and embodying growth.
Via: Omada Health Blog
By: Sean Duffy, Omada Health CEO
Martin Emerson has joined Monteris Medical Inc. as CEO about two months after his previous business, Galil Medical Inc., was sold in a deal worth up to $110 million.
"...In California and Washington state, San Francisco-based Omada Health is testing a version of Prevent, a diabetes and heart disease prevention program that's been modified for "underserved" populations -- basically people on Medicaid or who are uninsured. The free program offers patients a digital scale as well as behavior counseling and education, access to a personal health coach and an online peer network.